banner

Mayelana NATHI

Iphrofayela Yenkampani

I-Innovita Biological Technology Co., Ltd. (kanye nezinkampani ezingaphansi kwayo, ezaziwa ngokuhlanganyela ngokuthi “INNOVITA”,) yinkampani ye-biotechnology egxile ocwaningweni, ekuthuthukisweni, ekukhiqizweni nasekuthengisweni kwemikhiqizo ye-POCT yokuxilonga ye-in vitro. Iqukethe i-Innovita (Tangshan) , Innovita (Beijing) kanye ne-Innovata (Guangzhou).

● Yasungulwa ngo-2006

● Setha izikhungo ze-R&D e-Beijing nase-Guangzhou, kanye nesizinda sokukhiqiza e-Qian'an, Hebei

about-us (3)
about-us (23)

Iphrofayela Yenkampani

Yasungulwa ngo-2006, i-INNOVITA yakhe izinkundla eziyisithupha zobuchwepheshe ezifana nokulungiswa kwe-antigen & antibody, isiko legciwane, igolide le-colloidal, i-ELISA, i-fluorescence chromatography, i-immunofluorescence, futhi yenza uhlelo lwe-R&D lwe-Chinese National High-tech emkhakheni wocwaningo lwezifo ezithathelwanayo ezinkulu zikazwelonke kanye nokunye okuningi. eminye imiklamo yezempilo yomphakathi.Ngaphandle kwalokho, i-INNOVITA inamalungelo obunikazi okusungulwa kazwelonke angaphezu kweshumi futhi isungula isikhungo se-Beijing R&D, isikhungo se-R&D sase-Guangzhou, isizinda sokukhiqiza sase-Hebei.Ngamaworkshops amakhulu ahlanzekile, nokusetha igolide le-colloidal, i-ELISA, i-fluorescence chromatography, i-PCR, imigqa yokukhiqiza i-immunofluorescence, i-INNOVITA ithole isitifiketi se-CE kanye ne-ISO13485.

Njengamanje, imikhiqizo ye-INNOVITA iqukethe ukuhlolwa kokuxilongwa kokuphefumula, ukuhlolwa kokuzala, ukuhlolwa kwe-hepatitis, ukuhlolwa kwe-TORCH, ukuhlolwa kwenhliziyo nemithambo yegazi, ukuhlolwa kokusebenza kwezinso nokunye.Inethiwekhi yokuthengisa ihlanganise zonke izifundazwe nezifunda eChina, futhi yasakazekela eNingizimu-mpumalanga ye-Asia, Middle East, Africa, Latin America, European Union nezinye izifunda zaphesheya.I-INNOVITA ibambelela kufilosofi yebhizinisi eligxile kumakhasimende, futhi isiza amakhasimende ngemikhiqizo enembe kakhudlwana futhi elula.Izidingo zamakhasimende ziwukuphishekela kwe-INNOVITA.

Inqubo Yokuthuthukisa

  • Ngo-2006
    ● Kusungulwe isikhungo se-R&D sase-Beijing.
  • Ngo-2011
    ● Kusungulwe izindawo zokukhiqiza zaseTangshan.
  • Ngo-2014
    ● Isitifiketi se-ISO 13485.
  • Ngo-2018
    ● Ukutshalwa kwezimali kwamasu yiGenesis Capital.
    ● Uqale ukubambisana kwamazwe ngamazwe kwezobuchwepheshe.
  • Ngo-2019
    ● Ukutshalwa kwezimali kwamasu yi-Sequoia Capital.
  • Ngo-2020
    ● I-NMPA yokuqala igunyaze Ukuhlolwa kwe-COVID-19 IgM/IgG Combo.
    ● Kuthekeliswe emazweni/izindawo ezingaphezu kuka-70.
    ● Iklonyeliswe Ngeqoqo Elithuthukile kuKhongolose Kazwelonke Yokuncoma Yokulwa Nobhubhane lwe-COVID-19.
    ● Ukuhlolwa kwe-COVID-19 IgM/IgG kutholwe Ukugunyazwa Kokusetshenziswa Kwezimo Eziphuthumayo (EUA) yi-US FDA.
  • Ngo-2022
    ● Umhlangano wokuqala wokwethulwa ku-SSE STAR Market, futhi uzofakwa ohlwini lwe-China Sci-Tech Innovation Board maduze.
  • Amagatsha

    about-us (7)

    I-Beijing R&D & Marketing Center

    Ukusungulwa:2006

    Gxila:I-R&D, ukukhiqiza, ukumaketha komkhiqizo wokuxilonga we-in-vitro, okuhlanganisa izinkundla ezifana ne-immunodiagnosis, ukuxilongwa kwamangqamuzana, nama-gene chips.

    I-Qian'an Manufacturing & Logistic Center

    Ukusungulwa:2011

    Indawo:Ihlanganisa indawo engamahektha ayi-150, indawo yokusebenzela ezungeze i-8,000 ㎡, ifakwe imigqa eminingi yokukhiqiza yegolide eli-colloidal, i-ELISA, i-PCR.

    Isitifiketi:ISO 13485, CE, FDA, NMPA, njll.

    Isikhungo se-R&D sase-Guangzhou

    Ukusungulwa:2020

    Gxila:I-R&D yobuchwepheshe be-IVD

    Amapulatifomu

    plate

    I-Marketing Network

    Ngemva kweminyaka yokuthuthuka, i-Innovita isivele inenethiwekhi ephelele yokuthengisa nesevisi, eneziteshi zokuthengisa ezihlanganisa izifundazwe nezifunda ezingu-32 kulo lonke elaseShayina, futhi isithumele izimakethe zomhlaba wonke njengeSoutheast Asia, Middle East, Africa, Latin America, Europe, njll.

    Ukuhlolwa kwe-Innovita 2019-nCoV Ab kukhonjiswe endaweni yezimo eziphuthumayo kazwelonke yemithi nemishini yezokwelapha

    Ngomhla zingama-28 kuNhlolanja 2020, uNdunankulu uLi Keqiang wahlola inkundla kazwelonke yezimo eziphuthumayo yemithi nemishini yezokwelapha ye-COVID-19.I-Innovata 2019-nCoV Ab Test iboniswe njengokuhlolwa kokuqala kwe-IgM/IgG combo antibody okugunyazwe yi-NMPA, okwabikwa ku-CCTV.

    about-us (26)
    about-us (11)

    Ukuhlolwa kwe-Innovata 2019-nCoV Ab okuqanjwe i-Academician Zhong Nanshan

    ● Ntambama yangomhla zingama-23 kuNhlolanja 2020, isazi sezemfundo u-Zhong Nanshan sidalule ngesikhathi sezingxoxo ezikude e-Guangzhou nethimba lezokwelapha lase-Guangdong elaliphuthuma ukusiza i-Jingzhou ukuthi i-National Medical Products Administration igunyaze izinsiza ezimbili ezintsha zokuhlola ze-2019-nCoV, enye yazo okuwukuthi ikhiqizwe ngabakwa-Innovita (Tangshan) Biological Technology Co., Ltd.

    ● Ikhithi isebenzisa indlela yegolide ye-colloidal, ekwazi ukubona i-antibody ye-lgM emzimbeni wesiguli.I-antibody ye-lgM ingatholwa ngosuku lwe-7 lokutheleleka kwesiguli noma ngosuku lwe-3 ukuqala, okuwusizo kakhulu ekuxilongweni kwesiguli okuqhubekayo.UZhong Nanshan uthe: "Iziguli zingahlonzwa ngokushesha ukuze zixilongwe kahle. Lokhu kungasisiza ukuthi sihlukanise ngokushesha abantu abavamile kwabanegciwane."

    about-us (15)

    Advanced Collective Award

    about-us (8)

    Ukulwa Nobhubhane

    Combating Pandemic